Richard Berman: traditional palliative care no longer serves the cancer population

Richard Berman

The world around palliative care has changed. Patients are not just living for longer. They are, in many cases, now living with cancer for significant periods of time.

A tsunami is coming.

Decades of investment in cancer treatments are paying off. The push to improve survival, our application of cancer genomics coupled with the explosion of targeted systemic anti-cancer therapies (SACT) is transforming the field of oncology (1). More and more people are surviving the disease. Many will live for longer, much longer, even with incurable disease. We now talk of ‘metastatic cancer survivorship’ (2), of ‘late effects’ (even in those on palliative treatments), and of ‘living with and beyond’ cancer.

So now a hard truth: The traditional palliative care approach no longer fully serves the needs of the cancer population. Twenty years ago, we could celebrate the integration of palliative care within oncology as being a pinnacle point in the provision of a wholly comprehensive package of care for people with the disease. End of life care still remains a hugely important component of cancer care. But things are getting very, very different. The world around palliative care has changed. Patients are not just living for longer. They are, in many cases, now living with cancer for significant periods of time. And with many of the newer targeted therapies having lower toxicity profiles than conventional chemotherapy, patients have come to expect a reasonable quality of life during their cancer journey. This does not mean this time period is without burden. On the contrary, prolonged periods of chronic ill health bring with them a complexity of physical, psychosocial and spiritual issues.

Richard Berman

The need for what is becoming known as “supportive care” (or more recently “supportive oncology”) – which encompasses the entire cancer spectrum - has developed in response to a changing patient demographic and rise in said populations.

Palliative care developed in response to a pre-existing clinical need, initially prompted by a paradigm shift in how we manage terminal illness. The need for what is becoming known as “supportive care” (or more recently “supportive oncology”) – which encompasses the entire cancer spectrum - has developed in response to a changing patient demographic and rise in said populations. The Multinational Association of Supportive Care in Cancer (MASCC) defines this as ‘the prevention and management of the adverse effects of cancer and cancer treatments’. Optimal supportive oncology requires input from a broad range of medical and non-medical specialties working in an integrated way across the whole cancer pathway. Palliative care, with some tweaking (3), has a part in this, but can no longer be regarded as the sole provider. Alongside this, the research base to help guide our clinical practice in these groups is distinctly lacking. For example, how we manage pain at the end of life cannot the same as how we manage pain in those living with the disease for many years, or in those who have survived the disease. How we manage sickness at the end of life is very different from how we prevent/manage sickness induced by chemotherapy (1).

Palliative care is, alongside other supportive specialties, an essential component of supportive oncology. Indeed in many centres, early development of supportive oncology (often implemented through the Enhanced Supportive Care initiative) has been led by palliative care teams. In cancer, treatment advances and changing populations are triggering an urgent re-think in how we deliver care. Palliative care, as a specialty, has a great opportunity to embrace this. Not doing so may risk further side-lining the specialty.

Reference

(1) Berman R, Laird BJA, Minton O, Monnery D, Ahamed A, Boland E, Droney J, Vidrine J, Leach C, Scotté F, Lustberg MB, Lacey J, Chan R, Duffy T, Noble S. The Rise of Supportive Oncology: A Revolution in Cancer Care. Clin Oncol (R Coll Radiol). 2023 Apr;35(4):213-215. doi: 10.1016/j.clon.2023.01.015. Epub 2023 Jan 23. PMID: 36737312.

(2) Julia Lai-Kwon, Sarah Heynemann, Nicolas H. Hart, Raymond J. Chan, Thomas J. Smith, Larissa Nekhlyudov, and Michael Jefford

Evolving Landscape of Metastatic Cancer Survivorship: Reconsidering Clinical Care, Policy, and Research Priorities for the Modern Era

Journal of Clinical Oncology 2023 41:18, 3304-3310

(3) Power, J., Gouldthorpe, C. & Davies, A. Palliative care in the era of novel oncological interventions: needs some “tweaking”. Support Care Cancer 30, 5569–5570 (2022). https://doi.org/10.1007/s00520-022-07079-2

Richard Berman

Contributor: Richard Berman

@bermandr2

Read Time: 3m

Published

02 October 2023

Theme

Pathway improvement

Sub Theme

Delivering effective integrated care

About

Dr Berman graduated in medicine at Charing Cross and Westminster Medical School (University of London) in 1996. He initially trained as a GP and became a member of the Royal College of General Practitioners (MRCGP) in 2001. However, as a GP he developed a real interest in palliative and supportive care, so left general practice and enrolled on a specialist training programme for palliative medicine in 2002 (at the North West Deanery in Manchester, which oversees postgraduate medical education). He now works as Consultant in Palliative Medicine and Honorary Senior Lecturer at The Christie. His role involves management of pain and symptom control in cancer patients, to help them through treatment, as well as caring for patients with advanced disease and those towards the end of life.

Further resources

Blog

Dan Monnery: the nature of cancer care is changing

People with incurable cancer are achieving much longer survival due to improved treatments and earlier diagnoses. The way we support them needs to change as well.

Blog

Outpatient care strategy

The RCP and NHS England’s Outpatient Recovery and Transformation Programme are jointly working to develop a new strategy for outpatient care, setting out new ambitions for outpatient care and the actions we need to take to deliver real change.

Blog

Julie Want and Yuki Kano: Enhanced Supportive Care at the Royal Marsden NHS Foundation Trust

Our aim is to support patients early in their cancer journey and, alongside cancer treatment, by offering proactive symptom control and psychological, social, and practical support.